SNORD113-3: SNORD113-3 is a small nucleolar RNA (snoRNA) that is upregulated in post-therapeutic LACC samples compared to pre-therapeutic LACC samples [PMC9267054]. It is also found to be upregulated in acute promyelocytic leukemia (APL) compared to other types of hematologic tumors [PMC8629011]. SNP rs2400963 is located in the SNORD113-3 gene [PMC6202974]. In lymph node-positive invasive ductal carcinoma (LN+ IDC), SNORD113-3 is both deleted and downregulated compared to normal adjacent tissue [PMC8259224]. In a study of triple-negative breast cancer (TNBC) patients, SNORD113-3, along with other genes, showed corresponding changes in gene expression and were assessed for their prognostic value [PMC8259224]. However, no survival information was available for the deleted SNORD113-3 gene [PMC8259224]. In addition, the expression of SNORD113-3 was found to be significantly downregulated in a study on Dlk1 expression and other microRNAs in hepatocellular carcinoma [PMC4169825]. References: [PMC9267054] [PMC8629011] [PMC6202974] [PMC8259224] [PMC4169825]